IDYA

IDEAYA Biosciences develops cancer drugs tailored to patients based on genetic testing and molecular markers. The company has multiple drugs in development, including Darovasertib for eye cancer, IDE849 for lung cancer, and several others targeting specific genetic mutations or proteins found in tumors. Most of these drugs are still in clinical trials to test whether they work and are safe. The company partners with large pharmaceutical companies like GlaxoSmithKline, Pfizer, and Roche to test and develop these drugs.